pdf

Supramalleolar Osteotomy

July 1, 2015

Supramalleolar osteotomies are a surgical treatment option for asymmetric varus or valgus ankle arthritis where at least 50% of the joint surface is spared. Procedure selection requires significant preoperative planning for appropriate execution. Thus, the surgeon must be familiar with the principles of deformity correction.

Read the full article →

Metallic Hardware Not a Considered Complication

July 1, 2015

It is interesting that two different meta-analyses aimed to answer the same question. It should be made clear that reoperation for metallic hardware removal was not considered a complication in our report (1).

Read the full article →

The Difference Is in What Is or Is Not Included

July 1, 2015

We thank Journal Editor D. Scot Malay, DPM, MSCE, FACFAS, for his Editorial regarding both, seemingly overlapping, manuscripts. In addition to the differences correctly pointed out by Dr

Read the full article →

Metatarsus Primus Varus Correction

July 1, 2015

We present a discussion on the use of proximal first-ray osteotomies in the surgical treatment for hallux valgus as a valid option compared with first-tarsometatarsal arthrodesis. Recent and historical literature tells us that stability of the first ray is a function of the alignment and reestablishment of retrograde stabilizing forces at the first tarsometatarsal joint

Read the full article →

Perioperative Glycemic Control and the Effect on Surgical Site Infections in Diabetic Patients Undergoing Foot and Ankle Surgery

June 30, 2015

Introduction . Diabetes mellitus is one of the leading causes of hyperglycemia in the perioperative setting

Read the full article →

HbA1c and Lower Extremity Amputation Risk in Patients With Diabetes: A Meta-Analysis

June 30, 2015

In this meta-analysis, we aimed to assess glycosylated hemoglobin (HbA1c) level and lower extremity amputation (LEA) risk in patients with diabetes. Systematic computerized searches of the PubMed and Web of Knowledge were performed. We compared HbA1c level between groups with LEA and without LEA by meta-analysis; we also examined the dose–response relationship between HbA1c level and LEA risk

Read the full article →